These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19958645)

  • 1. [Expression characteristics of nuclear factor kappa B in hepatocellular carcinoma tissues].
    Zhou WM; Ping JL; Qian FC; Zhang GL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):843-6. PubMed ID: 19958645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis.
    Wu W; Yao DF; Qiu LW; Sai WL; Shen JJ; Yu HB; Wu XH; Li YM; Wang YL; Gu WJ
    Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):504-9. PubMed ID: 19822494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamic expression and quantitative analysis of hepatic nuclear factor-kappa B and its gene during the development of hepatocellular carcinoma].
    Dong ZZ; Yao DF; Yu HB; Gu WJ; Shen YC; Li YM; Wang YL; Shen JJ
    Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):669-73. PubMed ID: 18822207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma.
    Tai DI; Tsai SL; Chang YH; Huang SN; Chen TC; Chang KS; Liaw YF
    Cancer; 2000 Dec; 89(11):2274-81. PubMed ID: 11147598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
    Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
    Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of p16 and Rb protein expression and NF-kappaB activity on hepatocarcinogenesis].
    Wang ZW; Peng ZH; Tang HM; Qiu GQ; Xing TH; Yang MZ
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):225-8. PubMed ID: 15059540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of tyrosine kinase Etk/Bmx and its relationship with AP-1- and NF-kappaB-associated proteins in hepatocellular carcinoma.
    Guo L; Guo Y; Xiao S
    Oncology; 2007; 72(5-6):410-6. PubMed ID: 18196928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
    Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
    Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
    Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
    Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y
    Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of liver injury in severe acute pancreatitis rats and role of melatonin].
    Ni Y; Wu JS; Fang PP; Wu XL; Sun XC; Jia GB; Zhang RZ
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2867-71. PubMed ID: 19080501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics.
    Lee TH; Tai DI; Cheng CJ; Sun CS; Lin CY; Sheu MJ; Lee WP; Peng CY; Wang AH; Tsai SL
    J Biomed Sci; 2006 Jan; 13(1):27-39. PubMed ID: 16228287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].
    Peng SH; Yang JF; Xie PP; Deng H; Li H; Feng DY
    Ai Zheng; 2005 Jun; 24(6):695-8. PubMed ID: 15946481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
    Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
    Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
    Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM
    Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of NF-kappaB in hepatocellular carcinoma cell.
    Wang J; Huang Q; Chen M
    Chin Med J (Engl); 2003 May; 116(5):747-52. PubMed ID: 12875694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of NF-kappa B pathway on apoptosis of hepatic carcinoma cell line-7721 induced by TNF-alpha].
    Yang JY; Zeng XY; Ma BR
    Ai Zheng; 2002 Sep; 21(9):974-8. PubMed ID: 12508545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q; Liang LJ; Peng BG; Zhen YY
    Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.